ZEGFROVY
LIVE

Serial Number

97447022

Owner

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Attorney

He Li

First Use Date

Dec 4, 2023

Filing Date

Jun 7, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ZEGFROVY Trademark

Serial Number: 97447022 • Registration: 7654958

ZEGFROVY is a trademark filed by Dizal (Jiangsu) Pharmaceutical Co., Ltd. on June 7, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Square, No.26 Hefeng Rd., Xinwu District
Wuxi City, Jiangsu 201203 , CN

Entity Type: 03

Trademark Details

Filing Date

June 7, 2022

Registration Date

January 14, 2025

First Use Anywhere

December 4, 2023

First Use in Commerce

December 4, 2023

Published for Opposition

June 27, 2023

Goods & Services

Acids for pharmaceutical purposes; adjuvants for medical purposes; agricultural fungicide; aluminum acetates for pharmaceutical purposes; amino acids for medical purposes; analgesics; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; antibiotic, sunburn and anti-inflammatory ointments for pharmaceutical purposes; antibiotics; antioxidant pills for medical use; antiseptics; astringents for medical purposes; bacterial culture mediums; bacterial poisons; bacterial preparations for medical purposes for researching of human illnesses; bacteriological research preparation, namely, preparations of reports for anti-tumor treatment for medical purposes; balsamic preparations for medical purposes; biological agents for the treatment of cancer; biological preparations for medical purposes for treatment of human illnesses; biological tissue cultures for medical purposes; blood for medical purposes; blood plasma; bouillons for bacteriological cultures; bronchodilating preparations; by-products of the processing of cereals for dietetic or medical purposes; cachets in the nature of capsules for medicinal preparations for the mouth for pharmaceutical purposes; candy for medical purposes; candy for pharmaceutical purpose for treatment of the cough; capsules made of dendrimer-based polymers for medicinal preparations for the mouth, for pharmaceuticals purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations as medicines for medical purposes, namely, for anti-tumor treatment; chemical preparations for pharmaceutical purposes for the treatment of human illnesses, namely, anti-tumor treatment; chemical reagents for medical purposes for the treatment of human illnesses; chemico-pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; chewing gum for medical purposes; Chinese medicine nostrum for the treatment of tumors in humans; collyrium; contact lens cleaning preparations; contact lens disinfectant; contact lenses care solution; cough pastilles for pharmaceutical purposes; crystallized rock sugar for medical purposes; depuratives for the body; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dietetic substances of low sugar and salt adapted for medical use; digestives for pharmaceutical purposes; drugs for medical purposes for treatment of human illnesses, namely, anti-tumor treatment; enzyme preparations for medical purposes; enzymes for medical purposes; esters for pharmaceutical purposes; ethers for pharmaceutical purposes; eye drops; filled portable medicine cases, comprised of pharmaceuticals for treatment of human illnesses, namely, anti-tumor treatment; first-aid boxes, filled; fungicides; gelatine for medical purposes, namely, gelatin capsules sold empty; germicides; herbal teas for medicinal purposes; insect killing preparations in the nature of pesticides; insecticidal veterinary washes; insecticides; isotopes for medical purposes; media for bacteriological cultures; medical diagnosis reagent; medical probiotic supplements; medicated eye-washes; medicated lozenges for pharmaceutical purposes; medicinal drinks; medicinal hair growth preparations; medicinal preparations for the mouth to be applied in the form of capsules; medicines for alleviating constipation; medicines for dental purposes; mineral, bath and sodium salts for medical purposes; ophthalmic pharmaceutical products for anti-tumor treatment; ophthalmic preparations; opotherapy preparations; organotherapy preparations; pesticides; petroleum jelly for medical purposes; pharmaceutical blood preparations, namely, a blood clotting aid and delivery system for use in human medicine; pharmaceutical preparation for application to the eye or intraocular surgery for the purpose of anti-tumor treatment; pharmaceutical preparations for skin care; pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; pharmaceutical preparations, namely, elixirs for anti-tumor treatment; phytotherapy preparations for medical purposes; pre-filled syringes of medicines for medical treatment purposes, namely, anti-tumor treatment; preparations for destroying noxious animals; protein dietary supplements; radioactive substances for medical purposes; radiological contrast substances for medical purposes; rat poison; raw material drugs, namely, pharmaceuticals for anti-tumor treatment; reagent paper for medical purposes; reagent paper for veterinary purposes; rubbing alcohol; solutions for contact lenses; stem cells for medical purposes; sterilizing preparations; styptic preparations; tonics being pharmaceutical preparations for the treatment of human illnesses, namely, anti-tumor treatment; vaccine preparations; bacteriological preparations for veterinary use; cultures of microorganisms for veterinary use; chemical reagents for veterinary purposes; veterinary preparations for the treatment of intestinal bacteria; diagnostic preparations for veterinary use

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 16, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 16, 2026 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 16, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 16, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 16, 2026 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 14, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 14, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 28, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 28, 2024 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2024 CRFA
ASSIGNED TO LIE
Oct 2, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 11, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 15, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 15, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Mar 15, 2024 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Feb 29, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 29, 2024 AITU
USE AMENDMENT FILED
Feb 6, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 6, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 22, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 27, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 27, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 7, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 25, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 22, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 22, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 22, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 22, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 22, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 17, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 16, 2022 NWOS
NEW APPLICATION ENTERED
Jun 10, 2022 NWAP